Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

osteosarcoma

  • You have access
    Risk Factors for Hepatic Toxicity of High-dose Methotrexate in Patients With Osteosarcoma
    KENTARO ABE, AYAKO MAEDA-MINAMI, TAKU ISHIZU, SHINTARO IWATA, EISUKE KOBAYASHI, TATSUNORI SHIMOI, YOHEI KAWANO, HIRONOBU HASHIMOTO, MASAKAZU YAMAGUCHI, TETSUYA FURUKAWA, SATORU MIYAZAKI and YASUNARI MANO
    Anticancer Research February 2022, 42 (2) 1043-1050; DOI: https://doi.org/10.21873/anticanres.15565
  • You have access
    Pretreatment Neutrophil Count and Platelet-lymphocyte Ratio as Predictors of Metastasis in Patients With Osteosarcoma
    YOSHIHIRO ARAKI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, AKIHIKO TAKEUCHI, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, KENSAKU ABE, YUTA TANIGUCHI, HIROTAKA YONEZAWA, SEI MORINAGA, YOHEI ASANO and HIROYUKI TSUCHIYA
    Anticancer Research February 2022, 42 (2) 1081-1089; DOI: https://doi.org/10.21873/anticanres.15570
  • You have access
    Oral-recombinant Methioninase Converts an Osteosarcoma from Methotrexate-resistant to -sensitive in a Patient-derived Orthotopic-xenograft (PDOX) Mouse Model
    YUSUKE AOKI, YASUNORI TOME, QINGHONG HAN, JUN YAMAMOTO, KAZUYUKI HAMADA, NORIYUKI MASAKI, YUTARO KUBOTA, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN
    Anticancer Research February 2022, 42 (2) 731-737; DOI: https://doi.org/10.21873/anticanres.15531
  • You have access
    Osteosarcoma Patient-derived Orthotopic Xenograft (PDOX) Models Used to Identify Novel and Effective Therapeutics: A Review
    TAKASHI HIGUCHI, KENTARO IGARASHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, MICHAEL BOUVET, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN
    Anticancer Research December 2021, 41 (12) 5865-5871; DOI: https://doi.org/10.21873/anticanres.15406
  • You have access
    The Thioredoxin-1 Inhibitor, PX-12, Suppresses Local Osteosarcoma Progression
    HIDEYUKI KINOSHITA, OSAMU SHIMOZATO, TAKESHI ISHII, HIROTO KAMODA, YOKO HAGIWARA, SEIJI OHTORI and TSUKASA YONEMOTO
    Anticancer Research December 2021, 41 (12) 6013-6021; DOI: https://doi.org/10.21873/anticanres.15420
  • You have access
    Effects of Hypoxia on Proliferation and Apoptosis of Osteosarcoma Cells
    SHANG-YOU YANG, ELKA GARCIA, WILL XIA and ANYU WANG
    Anticancer Research October 2021, 41 (10) 4781-4787; DOI: https://doi.org/10.21873/anticanres.15293
  • You have access
    The Thioredoxin Reductase Inhibitor Auranofin Suppresses Pulmonary Metastasis of Osteosarcoma, But Not Local Progression
    HIDEYUKI KINOSHITA, OSAMU SHIMOZATO, TAKESHI ISHII, HIROTO KAMODA, YOKO HAGIWARA, TOSHINORI TSUKANISHI, SEIJI OHTORI and TSUKASA YONEMOTO
    Anticancer Research October 2021, 41 (10) 4947-4955; DOI: https://doi.org/10.21873/anticanres.15308
  • You have access
    Combination of CDK4/6 and mTOR Inhibitors Suppressed Doxorubicin-resistant Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse Model: A Translatable Strategy for Recalcitrant Disease
    HIROMICHI OSHIRO, YASUNORI TOME, KENTARO MIYAKE, TAKASHI HIGUCHI, NORIHIKO SUGISAWA, FUMINORI KANAYA, KOTARO NISHIDA and ROBERT M. HOFFMAN
    Anticancer Research July 2021, 41 (7) 3287-3292; DOI: https://doi.org/10.21873/anticanres.15115
  • Open Access
    Oral-recombinant Methioninase Converts an Osteosarcoma from Docetaxel-resistant to -Sensitive in a Clinically-relevant Patient-derived Orthotopic-xenograft (PDOX) Mouse Model
    YUSUKE AOKI, YASUNORI TOME, NATHANIEL F. WU, JUN YAMAMOTO, KAZUYUKI HAMADA, QINGHONG HAN, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN
    Anticancer Research April 2021, 41 (4) 1745-1751; DOI: https://doi.org/10.21873/anticanres.14939
  • Open Access
    Eribulin Inhibits Osteosarcoma in a Clinically-accurate Bone-tumor-insertion PDOX Mouse Model
    NATHANIEL F. WU, JUN YAMAMOTO, YUSUKE AOKI, MICHAEL BOUVET and ROBERT M. HOFFMAN
    Anticancer Research April 2021, 41 (4) 1779-1784; DOI: https://doi.org/10.21873/anticanres.14943

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire